These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 12428362)

  • 1. [Posttranslational modifications of microtubule associated protein tau].
    Miyasaka T; Takashima A
    No To Shinkei; 2002 Sep; 54(9):753-66. PubMed ID: 12428362
    [No Abstract]   [Full Text] [Related]  

  • 2. Tauopathies.
    Hernández F; Avila J
    Cell Mol Life Sci; 2007 Sep; 64(17):2219-33. PubMed ID: 17604998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau phosphorylation and aggregation in Alzheimer's disease pathology.
    Avila J
    FEBS Lett; 2006 May; 580(12):2922-7. PubMed ID: 16529745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tau protein abnormality and dementia: the mechanisms of neurodegeneration].
    Tanaka T; Takeda M
    No To Shinkei; 2002 Sep; 54(9):777-87. PubMed ID: 12428364
    [No Abstract]   [Full Text] [Related]  

  • 5. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype-phenotype correlations in FTDP-17: does form follow function?
    Forman MS
    Exp Neurol; 2004 Jun; 187(2):229-34. PubMed ID: 15144848
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tauopathy and Alzheimer disease: a full degenerating process].
    Buée L; Delacourte A
    Psychol Neuropsychiatr Vieil; 2006 Dec; 4(4):261-73. PubMed ID: 17194646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease.
    Guillozet-Bongaarts AL; Garcia-Sierra F; Reynolds MR; Horowitz PM; Fu Y; Wang T; Cahill ME; Bigio EH; Berry RW; Binder LI
    Neurobiol Aging; 2005 Jul; 26(7):1015-22. PubMed ID: 15748781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zeta 14-3-3 protein favours the formation of human tau fibrillar polymers.
    Hernández F; Cuadros R; Avila J
    Neurosci Lett; 2004 Mar; 357(2):143-6. PubMed ID: 15036595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural insights into Alzheimer filament assembly pathways based on site-directed mutagenesis and S-glutathionylation of three-repeat neuronal Tau protein.
    Dinoto L; Deture MA; Purich DL
    Microsc Res Tech; 2005 Jul; 67(3-4):156-63. PubMed ID: 16104002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel isoforms of tau that lack the microtubule-binding domain.
    Luo MH; Tse SW; Memmott J; Andreadis A
    J Neurochem; 2004 Jul; 90(2):340-51. PubMed ID: 15228591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-Dimensional Electrophoresis Protocols to Analyze the Microtubule-Associated Tau Proteins from Several Biological Sources.
    Sergeant N; Fernandez-Gomez FJ; Obriot H; Eddarkaoui S; Buée-Scherrer V; Buée L
    Methods Mol Biol; 2017; 1523():251-261. PubMed ID: 27975254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phosphorylation of tau and Alzheimer's disease].
    García T; Jay D
    Gac Med Mex; 2004; 140(3):329-33. PubMed ID: 15259345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.
    Ferrer I; Barrachina M; Puig B; Martínez de Lagrán M; Martí E; Avila J; Dierssen M
    Neurobiol Dis; 2005 Nov; 20(2):392-400. PubMed ID: 16242644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of tau protein in both physiological and pathological conditions.
    Avila J; Lucas JJ; Perez M; Hernandez F
    Physiol Rev; 2004 Apr; 84(2):361-84. PubMed ID: 15044677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemistry of Tau in Alzheimer's disease and related neurological disorders.
    Sergeant N; Bretteville A; Hamdane M; Caillet-Boudin ML; Grognet P; Bombois S; Blum D; Delacourte A; Pasquier F; Vanmechelen E; Schraen-Maschke S; Buée L
    Expert Rev Proteomics; 2008 Apr; 5(2):207-24. PubMed ID: 18466052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studying posttranslational modifications by in-cell NMR.
    Lippens G; Landrieu I; Hanoulle X
    Chem Biol; 2008 Apr; 15(4):311-2. PubMed ID: 18420137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-Synuclein and its disease-related mutants interact differentially with the microtubule protein tau and associate with the actin cytoskeleton.
    Esposito A; Dohm CP; Kermer P; Bähr M; Wouters FS
    Neurobiol Dis; 2007 Jun; 26(3):521-31. PubMed ID: 17408955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of tau-induced neurodegeneration in Alzheimer disease and related tauopathies.
    Alonso AC; Li B; Grundke-Iqbal I; Iqbal K
    Curr Alzheimer Res; 2008 Aug; 5(4):375-84. PubMed ID: 18690834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memantine inhibits and reverses the Alzheimer type abnormal hyperphosphorylation of tau and associated neurodegeneration.
    Li L; Sengupta A; Haque N; Grundke-Iqbal I; Iqbal K
    FEBS Lett; 2004 May; 566(1-3):261-9. PubMed ID: 15147906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.